WallStreetZenWallStreetZen

NASDAQ: GHRS
Gh Research PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GHRS

Based on 3 analysts offering 12 month price targets for Gh Research PLC.
Min Forecast
$31.00+327.59%
Avg Forecast
$36.67+405.75%
Max Forecast
$40.00+451.72%

Should I buy or sell GHRS stock?

Based on 3 analysts offering ratings for Gh Research PLC.
Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GHRS stock forecasts and price targets.

GHRS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-09-05
lockedlocked$00.00+00.00%2024-09-04
lockedlocked$00.00+00.00%2024-05-06

1 of 1

Forecast return on equity

Is GHRS forecast to generate an efficient return?
Company
-30.38%
Industry
-781%
Market
49.42%
GHRS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GHRS forecast to generate an efficient return on assets?
Company
-29.16%
Industry
25.95%
GHRS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GHRS earnings per share forecast

What is GHRS's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$0.89
Avg 2 year Forecast
-$1.19
Avg 3 year Forecast
-$1.08

GHRS revenue forecast

What is GHRS's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$101.3M
Avg 2 year Forecast
$286.7M
Avg 3 year Forecast
$520.1M

GHRS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GHRS$7.25$36.67+405.75%Strong Buy
BMEA$10.41$40.70+290.97%Strong Buy
ANRO$13.91$36.00+158.81%Strong Buy
KRRO$39.25$105.00+167.52%Buy
CLYM$5.44N/AN/A
View Top Biotech Stocks

Gh Research Stock Forecast FAQ

Is Gh Research Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: GHRS) stock is to Strong Buy GHRS stock.

Out of 3 analysts, 1 (33.33%) are recommending GHRS as a Strong Buy, 2 (66.67%) are recommending GHRS as a Buy, 0 (0%) are recommending GHRS as a Hold, 0 (0%) are recommending GHRS as a Sell, and 0 (0%) are recommending GHRS as a Strong Sell.

If you're new to stock investing, here's how to buy Gh Research stock.

What is GHRS's earnings growth forecast for 2024-2026?

(NASDAQ: GHRS) Gh Research's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.51%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.85%.

Gh Research's earnings in 2024 is -$34,966,000.On average, 3 Wall Street analysts forecast GHRS's earnings for 2024 to be -$46,476,742, with the lowest GHRS earnings forecast at -$51,507,864, and the highest GHRS earnings forecast at -$39,021,109. On average, 3 Wall Street analysts forecast GHRS's earnings for 2025 to be -$61,913,493, with the lowest GHRS earnings forecast at -$78,042,218, and the highest GHRS earnings forecast at -$44,744,205.

In 2026, GHRS is forecast to generate -$56,190,397 in earnings, with the lowest earnings forecast at -$56,190,397 and the highest earnings forecast at -$56,190,397.

What is GHRS's revenue growth forecast for 2027-2029?

(NASDAQ: GHRS) Gh Research's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.86%.

Gh Research's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast GHRS's revenue for 2027 to be $5,270,451,089, with the lowest GHRS revenue forecast at $5,270,451,089, and the highest GHRS revenue forecast at $5,270,451,089. On average, 1 Wall Street analysts forecast GHRS's revenue for 2028 to be $14,916,469,172, with the lowest GHRS revenue forecast at $14,916,469,172, and the highest GHRS revenue forecast at $14,916,469,172.

In 2029, GHRS is forecast to generate $27,059,838,215 in revenue, with the lowest revenue forecast at $27,059,838,215 and the highest revenue forecast at $27,059,838,215.

What is GHRS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: GHRS) forecast ROA is -29.16%, which is lower than the forecast US Biotechnology industry average of 25.95%.

What is GHRS's Price Target?

According to 3 Wall Street analysts that have issued a 1 year GHRS price target, the average GHRS price target is $36.67, with the highest GHRS stock price forecast at $40.00 and the lowest GHRS stock price forecast at $31.00.

On average, Wall Street analysts predict that Gh Research's share price could reach $36.67 by Sep 5, 2025. The average Gh Research stock price prediction forecasts a potential upside of 405.75% from the current GHRS share price of $7.25.

What is GHRS's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: GHRS) Gh Research's current Earnings Per Share (EPS) is -$0.67. On average, analysts forecast that GHRS's EPS will be -$0.89 for 2024, with the lowest EPS forecast at -$0.99, and the highest EPS forecast at -$0.75. On average, analysts forecast that GHRS's EPS will be -$1.19 for 2025, with the lowest EPS forecast at -$1.50, and the highest EPS forecast at -$0.86. In 2026, GHRS's EPS is forecast to hit -$1.08 (min: -$1.08, max: -$1.08).

What is GHRS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: GHRS) forecast ROE is -30.38%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.